Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Steve R, Spaull"'
Autor:
Pamela Bowman, Kashyap A Patel, Timothy J McDonald, Jens J Holst, Bolette Hartmann, Maria Leveridge, Beverley M Shields, Suzie Hammersley, Steve R Spaull, Bridget A Knight, Sarah E Flanagan, Maggie H Shepherd, Rob C Andrews, Andrew T Hattersley
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 12, Pp 1378-1382 (2023)
Abstract The incretin hormones glucagon‐like peptide‐1 (GLP‐1) and glucose‐dependent insulinotropic polypeptide (GIP), are thought to be the main drivers of insulin secretion in individuals with sulfonylurea (SU)‐treated KCNJ11 permanent ne
Externí odkaz:
https://doaj.org/article/e365485b95a44b0ea326ca8035cedaad
Autor:
Pamela, Bowman, Timothy J, McDonald, Bridget A, Knight, Sarah E, Flanagan, Maria, Leveridge, Steve R, Spaull, Beverley M, Shields, Suzanne, Hammersley, Maggie H, Shepherd, Robert C, Andrews, Kashyap A, Patel, Andrew T, Hattersley
Publikováno v:
BMJ Open Diabetes Research & Care
Objective Insulin secretion in sulfonylurea-treated KCNJ11 permanent neonatal diabetes mellitus (PNDM) is thought to be mediated predominantly through amplifying non-KATP-channel pathways such as incretins. Affected individuals report symptoms of pos
Autor:
Timothy J. McDonald, Pamela Bowman, Steve R Spaull, Sarah E. Flanagan, Robert Andrews, Bridget A. Knight, Andrew T. Hattersley, Maggie Shepherd, Suzanne Hammersley, Maria Leveridge, Beverley M. Shields, Kashyap A. Patel
Publikováno v:
BMJ Open Diabetes Research & Care. 7:e000721
ObjectiveInsulin secretion in sulfonylurea-treated KCNJ11 permanent neonatal diabetes mellitus (PNDM) is thought to be mediated predominantly through amplifying non-KATP-channel pathways such as incretins. Affected individuals report symptoms of post